Erasca, Inc. Insider Trading

ERAS

Last 12 months

Insiders sold $2.28M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in May 2024.

Net open-market

−$2.28M

0 buys · 3 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

May 2024

May 21, 2024

Get an email when ERAS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Apr 1	Ebun Garner Chief Legal Officer	Sold10b5-1 plan	80,000	$16.40	$1.31M	76%	Form 4
Mar 4	Shannon Morris Chief Medical Officer	Sold10b5-1 plan	20,000	$15.04	301K	100%	Form 4
Jan 7	Ebun Garner General Counsel & Corp. Sec.	Sold10b5-1 plan	120,000	$5.59	671K	83%	Form 4

Apr 110b5-1 plan
Ebun Garner
Chief Legal Officer · sold 80,000 at $16.40
$1.31M
76% of stake
Mar 410b5-1 plan
Shannon Morris
Chief Medical Officer · sold 20,000 at $15.04
301K
100% of stake
Jan 710b5-1 plan
Ebun Garner
General Counsel & Corp. Sec. · sold 120,000 at $5.59
671K
83% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ERAS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ERAS

CompareIntrinsic value

AARDAardvark Therapeutics, Inc.

$1.26+2.44%10

ORMPOramed Pharmaceuticals Inc.

$4.13+3.25%35

NTHINeonC Technologies Holdings

$3.17+3.26%10

SLNSilence Therapeutics plc

$19.80+0.10%10

SEPNSepterna, Inc.

$47.88+9.57%46

AXSMAxsome Therapeutics, Inc.

$137.00-1.87%10

NKTXNkarta Inc.

$1.73+13.07%10

TNXPTonix Pharmaceuticals Holding Corp

$5.11-1.54%40

Held by ETFs

ERAS is in 57 US ETFs. The largest of them, with ERAS's weight in each:

Spot a number that looks wrong? Check it in ERAS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ERAS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.